BioNxt Solutions Inc.
Research BioNxt Solutions Inc. (BXT) on Bullrun: market cap EUR 31.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBXT
- ExchangeXETRA
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 31.85M
- Financial periodQ3 2025
- RevenueEUR 11.26K
- Net income-EUR 1.60M
- Free cash flow-EUR 2.03M
Valuation Snapshot
latest market cap is EUR 31.85M.
About BioNxt Solutions Inc.
BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis and myasthenia gravis; BNT24002 for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; BNT24004 for longevity and anti-aging; BNT24005 for solid organic transplantation;
Frequently asked questions
What is BioNxt Solutions Inc.'s market cap?
BioNxt Solutions Inc.'s market capitalization is EUR 31.85M.
What does BioNxt Solutions Inc. do?
BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis and myasthenia gravis;